ArticleJapanese journal of clinical oncology2024

Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study.

Nobukazu Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.